HOME >> MEDICINE >> NEWS
FDG-PET accurate for evaluating lung tumor destruction from radiofrequency ablation

FDG-PET can be used to assess the amount of tumor destruction after radiofrequency ablation (RFA)--the use of heat to destroy tumors--for the treatment of lung tumors and may provide more valuable information than CT alone, according to a new study.

For the study, researchers assessed 10 tumors in 10 patients who had lung tumors treated with CT-guided RFA and had PET scans both prior to RFA and following RFA. The researchers found that in seven out of 11 RFA treatments for the 10 patients, follow-up PET demonstrated persistent tumor activity. Two of the patients showed no activity on the follow-up PET, suggesting complete destruction of any active tumor. One patient had no definite change in the appearance of the mass, and another had a smaller lesion on follow-up PET.

"Usually, CT is used to assess tumor destruction, but CT cannot tell you whether a tumor is still alive--that is, actively metabolizing glucose--or dead in the area of destruction. It can also be difficult to assess how much of the ablated area is caused by an inflammatory reaction to the procedure. By using PET, the tumor cells that are still alive light up and the radiologist can better assess how much residual active tumor is left," said Jennifer Daly, MD, of the Newton-Wellesley Hospital in Newton, MA, and lead author of the study.

According to the researchers, without effective follow-up imaging, the radiologist has to gauge how successful it was based only on the patient's improvement in pain and maybe what is possibly seen on a post-ablation CT. "You don't really know for sure how much active tumor is destroyed unless you compare pre- and post-PET scans," said Dr. Daly.

The full results of the study will be presented on Monday, May 1, 2006 during the American Roentgen Ray Society Annual Meeting in Vancouver, BC.


'"/>

Contact: Necoya Lightsey
necoya@arrs.org
604-647-7413
American Roentgen Ray Society
1-May-2006


Page: 1

Related medicine news :

1. Dynamic sonography accurate in diagnosing muscle tears
2. Simple system accurately predicts weight-loss surgery risk
3. Prematurity more accurately predicted by advances in proteomic technology
4. MR angiography highly accurate in detecting blocked arteries
5. Imaging technique is highly accurate in diagnosing, locating pancreas defects in newborns
6. Prediction markets accurately forecast influenza activity
7. Workers compensation ratings dont accurately predict disabilities
8. Hospital performance measures may not accurately reflect quality of care or predict patient outcomes
9. New GreeneChip identifies multiple pathogens rapidly and accurately
10. GreeneChip -- New diagnostic tool that rapidly and accurately identifies multiple pathogens
11. Inexpensive test detects H5N1 infections quickly and accurately

Post Your Comments:
(Date:4/14/2014)... April 14, 2014 Popular web information on ... to read and doesn,t address the appropriate risks to ... Medical Center gastroenterologists suggests. , In a review of ... education materials for colorectal cancer screening were written beyond ... sites failed to address key risks, as well as ...
(Date:4/14/2014)... FRANCISCO, Calif.--True North Therapeutics, Inc., announced today a ... the destruction of human red blood cells exposed ... of autoimmune hemolytic anemia (AIHA). The article entitled ... prevents complement activation induced by cold agglutinin disease ... Blood earlier this month. TNT003 is ...
(Date:4/14/2014)... Frank Porter Graham Child Development Institute have released ... program to prepare four-year-olds for success in kindergarten. ... Pre-K show significant gains across all areas of ... even greater rate during their participation in NC ... senior scientist Ellen Peisner-Feinberg, who leads the FPG ...
(Date:4/14/2014)... Ohio Heart patients with beliefs about health that ... skip sessions of cardiac rehabilitation, new research suggests. , ... of these beliefs referred to as "irrational health ... was associated with lower adherence to a prescribed cardiac ... Doubting the preventive power of the flu vaccine or ...
(Date:4/14/2014)... high-risk bladder cancer, chemotherapy before or after surgery ... The findings are published early online in ... Cancer Society. , Clinical trials have shown that ... cancer who are given chemotherapy before surgery. There ... also improves survival. To investigate the use of ...
Breaking Medicine News(10 mins):Health News:Website information on colon cancer too complex, fails to address key concerns 2Health News:Website information on colon cancer too complex, fails to address key concerns 3Health News:Ex vivo efficacy of C1s antibody as Complement inhibitor in cold agglutinin disease 2Health News:Study gives high marks to NC Pre-K program 2Health News:Irrational health beliefs linked to skipping cardiac rehab sessions 2Health News:Irrational health beliefs linked to skipping cardiac rehab sessions 3
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... company developing its Symphony® CGM System as a ... that Robert F. Doman , Executive Chairman ... at "TEN", Noble Financial Capital Markets, Tenth Annual ... make a corporate presentation to prospective corporate partners ...
(Date:1/15/2014)... Quebec , Jan. 15, 2014  Valeant Pharmaceuticals ... VRX) announced that the applicable waiting period under the ... to the previously announced tender offer by its indirect ... the outstanding shares of common stock of Solta Medical, ... price of $2.92 per share, net to the seller ...
(Date:1/14/2014)... 14, 2014 HeartWare International, Inc ... innovator of less invasive, miniaturized circulatory support technologies ... failure, today announced that it expects revenues for ... $53 million, bringing expected full-year 2013 revenues to ... growth of 87% for 2013 above 2012 reflects ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
Cached News: